This is HUGE news! SurVaxM, a therapeutic cancer vaccine designed to delay the progression of the deadliest form of brain cancer, Glioblastoma, nearly DOUBLED the survival time of patients in an EARLY clinical trial.

Let’s talk about that! 🧵⬇️

— Chise (@sailorrooscout) June 13, 2023